Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study

Launched by ISTITUTO AUXOLOGICO ITALIANO · Jul 25, 2023

Keywords

ClinConnect Summary

This clinical trial is studying acromegaly, a rare condition caused by too much growth hormone in the body, often due to a benign tumor in the pituitary gland. The study aims to understand how acromegaly affects the size of patients' hands and feet, as well as their movement, by using advanced techniques like 3D scanning and gait analysis. Researchers want to compare newly diagnosed patients with those who have been living with the disease for different lengths of time.

To participate in this trial, you need to be at least 18 years old and either a newly diagnosed patient with acromegaly or someone with a different status of the disease. However, if you have certain health issues, previous surgeries on your bones or joints, or past injuries to your legs, you may not be eligible. If you join the study, you'll have your hand and foot measurements taken and your movement analyzed, which could help researchers learn more about how acromegaly affects everyday life for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • De novo patients with acromegaly (group # 1), diagnosed according to Endocrine Society guidelines,
• • Age equal to18 years or older
• • Acromegalic patients with different disease status (group #2)
• • Age equal to18 years or older
• Exclusion Criteria:
• • Cardiorespiratory, neurological or musculoskeletal disorder
• • Previous orthopaedic surgery
• • Previous lower limbs traumatic injuries